Use of artificial neural network for medical risk assessment analysis by Keivani Hafshejani, M. et al.
Life Science Journal 2012;9(4)                                                          http://www.lifesciencesite.com 
 
http://www.lifesciencesite.com        923                     lifesciencej@gmail.com  
Use of artificial neural network for medical risk assessment analysis 
 
Mariam K Hafshejani1, Manochehr Sattari Naeini2, Aboosaleh Mohammadsharifi3, Ameneh Langari*4 
 
1Shahrekord University of Medical Sciences, Shahrekord, Iran  
2Department of Biology, Naein Branch, Islamic Azad University, Naein, Iran  
3Engineering Group, Ramsar Branch, Islamic Azad University, Ramsar, Iran 
4 North Khorasan University of Medical Sciences, Bojnurd, Iran 
Corresponding author email: amenehlangari@yahoo.com 
 
Abstract: For new medical products and new drugs, unanticipated side effects that rise after consuming the new 
product is a dominant factor in decision making. In this project, an artificial neural network (NN) engine is designed 
and developed by the authors to the aim of a medical risk assessment. Firstly, an appropriate NN system is designed 
and trained. We mostly concerned with the procedure of how the developed NN construction and training. The 
designed NN for this case has three layers of neuron. These three layers include an input layer, a hidden layer and 
finally an output layer, with 25 neurons in the hidden layer. The results from NN models can match the data used for 
training. 
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1. Introduction 
Medical and health risk assessment is one of the 
powerful used screening tools in the field of health 
promotion and is often the first step in multi-
component health promotion programs. Moreover, 
Risk/benefit assessment plays an important role in 
market of new drugs, medical devices etc. (Al-Awa et 
al., 2012; Maghrabi, 2012). Risk assessment I a 
crucial stage in medical risk management. For new 
products, unanticipated side effects that rise after 
consuming the new product is a dominant factor. In 
addition, FDAs focused on ensuring the appropriate 
use of products in medical practice. Some reports 
have focused on the human/economic costs of 
medication errors, as well as serious adverse events 
that have occurred even when a medical product has 
been used appropriately (Report to the FDA 
commissioner, 1999). Risks have different source, 
hence effective management of each is different (See 
figure (1)). 
In this work we are going to use Neural Network 
(NN) for medical risk assessment. NN is a system 
based on the human brain (www.makhfi.com). It is 
inherently multiprocessor-friendly architecture and 
without much modification, it goes beyond one or 
even two processors of the von Neumann 
architecture. It has ability to account for any 
functional dependency. No need to postulate a model, 
to amend it, etc. Neural networks are a powerful 
technique to solve many real world problems. They 
typically consist of many simple processing units, 
which are wired together in a complex 
communication network (www.nr.no; Zernikow et al. 
1998). There is no central CPU following a logical 
sequence of rules - indeed there is no set of rules or 
program (www.makhfi.com; Shahbaz et al., 2012; 
Yang et al., 2012). This structure then is close to the 
physical workings of the brain and leads to a new 
type of computer that is rather good at a range of 
complex tasks. 
 
 
Figure 1. sources of risk from medical products 
(Report to the FDA commissioner, 1999). 
 
Regardless of the prevention techniques 
employed, possible threats that could arise the health 
need to be assessed. Although the exact nature of 
potential disease or disasters is difficult to determine, 
it is beneficial to perform a comprehensive medical 
risk assessment of all threats that can realistically 
occur to the public health. Quantitative risk 
assessment employs two fundamental elements; the 
probability of an event occurring and the likely loss 
should it occur. Quantitative risk analysis makes use 
of a single figure produced from these elements 
(www.nr.no; Zernikow et al. 1998).. This is called 
the 'Annual Loss Expectancy (ALE)' or the 
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'Estimated Annual Cost (EAC)'. This is calculated for 
an event by simply multiplying the potential loss by 
the probability (Balabin &  Lomakina, 2009). In this 
paper, based on an available database, medical risk 
assessment performed on a typical fault tree. A NN 
system is designed and trained. This paper is mostly 
concerned with the procedure of NN construction and 
training. 
 
2. Fault tree  
For this work, in this section a simple fault tree 
could be considered as has been shown in figure 2. 
This is a typical fault tree to be applied for designing 
an artificial Neural Network. 
 
Figure 2. Typical fault tree 
 
3. Available Data Base 
Table 1 includes a part of the available data base, 
performed from our project on risk assessment. 
 
 
Table 1. Some sets of the fuzzy data base (32768 points) 
Frequency  
of set1 
Frequency 
 of set2 
Frequency 
 of set 3 
Frequency  
of set 4 
Frequency  
of set 5 
Overall frequency 
1.25  1.25 1.25  1.25  1.25 1.375 
1.25  1.25  1.25 1.25  1.75 1.425 
1.25 1.25  1.25  1.25  2.25 1.575 
1.25  1.25  1.25  1.75 2.25 1.625 
1.25  1.25  1.25 2.75  4.75 2.275 
1.25  1.75  1.25 3.25 3.75 2.275 
1.25  1.75  3.25 2.75 4.75 2.725 
2.25  2.75  3.25 1.75  4.75 2.925 
3.25 4.75  1.25 2.75 4.75 3.325 
4.75 4.75  4.75 4.75 4.75 4.62 
 
Table 2. Sample of the normalized training data base (32768 points) 
Set  1 Set  2 Set  3 Set 4 Set 5 Overall frequency 
0.0625 0.0625 0.0625 0.0625 0.0625 0.09375 
0.0625 0.0625 0.0625 0.0625 0.1875 0.10625 
0.0625 0.0625 0.0625 0.0625 0.3125 0.14375 
0.0625 0.0625 0.0625 0.1875 0.3125 0.15625 
0.0625 0.0625 0.0625 0.4375 0.9375 0.31875 
0.0625 0.1875 0.0625 0.5625 0.6875 0.31875 
0.0625 0.1875 0.5625 0.4375 0.9375 0.43125 
0.3125 0.4375 0.5625 0.1875 0.9375 0.48125 
0.5625 0.9375 0.0625 0.4375 0.9375 0.58125 
0.9375 0.9375 0.9375 0.9375 0.9375 0.905 
 
4. Data Normalization  
We normalize the data points to be within a 
specific range. Therefore, the data points are 
normalized to the range of [0,1] interval. Please note 
that, the raw data points could be used as they are all 
in the range of 1 to 5. 
5. The Neural Network Constructed 
This topology of the constructed neural network 
is shown in figure 3. The hidden layer includes 25 
neurons. 
6. The ANN Training Performance 
The Levenberg-Marquardt algorithm, as a 
powerful off-line batch training method for neural 
networks, is used for training. The learning rate is 
0.005. It’s run to epoch 300. The final fitness is 
0.000187721 (MSE). The performance of training the 
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assumed neural network is shown in figure 4. The 
Levenberg-Marquardt algorithm is used for this aim 
and the learning rate is 0.005. 
 
 
Figure 3. Applied neural network 
 
 
Figure 4. Training performance 
 
7. Conclusions 
Medical and health risk assessment is one of the 
most widely used screening tools in the field 
of health promotion and is often the first step in 
multi-component health promotion programs. 
Moreover, Risk/benefit assessment plays an 
important role in market of new drugs, medical 
devices etc.. In this paper, an artificial neural network 
engine is designed and trained to be applied for a 
systematic medical risk assessment. The designed 
neural network for this case has three layers of 
neuron, input layer, hidden layer and output layer, 
with 25 neurons in the hidden layer. The results from 
artificial neural network models can match the data 
used for training. The Levenberg-Marquardt 
algorithm is used for this aim and the learning rate is 
0.005. 
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